News from Sanofi Pasteur Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

31 Jan, 2017, 08:00 ET Sanofi Pasteur Announces the Availability of Quadracel™ DTaP-IPV Vaccine for Children 4 Through 6 Years of Age in the U.S.

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the availability of Quadracel™ (Diphtheria and...


26 Jul, 2016, 08:00 ET Sanofi Pasteur Ships First of its 2016-2017 Seasonal Influenza Vaccine Doses in United States

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone®...


23 Jun, 2016, 07:56 ET New Four-Strain Influenza Vaccine, VaxigripTetra™, Regulatory Dossier from Sanofi Pasteur Now Approved in Europe

New VaxigripTetra™ vaccine:  - A 4-strain influenza vaccine for people 36 months of age and older,  - Helps protect...


20 Oct, 2015, 03:00 ET Un réseau international d'hôpitaux fait le bilan des formes sévères de la grippe saisonnière 2014-2015 lors de sa réunion annuelle

- La grippe peut entraîner un taux important d'hospitalisations à travers le monde -   - La vaccination réduit de façon significative le risque...


15 Oct, 2015, 11:00 ET Sanofi Pasteur and the Infectious Disease Research Institute Partner on a Global-Health, Open-Innovation, Vaccine Research & Development Center

Sanofi Pasteur, the vaccines division of Sanofi, announced today the creation of a Global Health Vaccine Center of Innovation (GHVCI) with the...


12 Dec, 2014, 08:00 ET Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...


03 Nov, 2014, 08:30 ET Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration...


08 Sep, 2014, 14:14 ET FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration...


13 Aug, 2014, 17:00 ET Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published...


22 Jul, 2014, 08:45 ET Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone® (Influenza...


19 May, 2014, 12:37 ET Sanofi Pasteur annonce des résultats encourageants pour l'essai de Phase II du candidat vaccin Clostridium difficile au congrès de l'ECCMID

- L'étude montre que le vaccin induit une réponse immunitaire contre les principales toxines et permet d'identifier le dosage pour les essais de...


19 May, 2014, 08:00 ET Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational...


12 May, 2014, 08:19 ET National Survey Reveals Mothers Are Unaware of the CDC Recommendations for Prevention of Meningococcal Meningitis, a Disease That Can Potentially Kill in 24 Hours

Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,1 a national survey revealed that more...


01 Apr, 2014, 09:13 ET Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has...


03 Mar, 2014, 01:00 ET Les enfants du monde entier vont pouvoir bénéficier du vaccin polio inactivé, dans le cadre de l'éradication de la poliomyélite

- Sanofi Pasteur travaille avec ses partenaires internationaux pour fournir des quantités inégalées de vaccin polio inactivé...


03 Feb, 2014, 03:00 ET Sanofi Pasteur lance une étude de phase III du vaccin candidat contre le Clostridium difficile en France

- L'essai clinique Cdiffense™ évaluera le vaccin contre une des principales causes d'infections nosocomiales potentiellement mortelles dans le...


24 Sep, 2013, 09:30 ET March of Dimes and Sanofi Pasteur Launch Sounds of Pertussis® "Grandparents' Corner" to Help Grandparents Better Protect Their Families from Whooping Cough

 March of Dimes and Sanofi Pasteur today launched Grandparents' Corner, a new online resource from the Sounds of Pertussis® Campaign, to...


19 Sep, 2013, 08:00 ET Sanofi Pasteur is on the Hunt for The FLUgitives™ This Flu Season

 To help encourage more Americans to get their annual flu shot, Sanofi Pasteur announced today the launch of a national campaign to round up...


26 Aug, 2013, 08:00 ET Sanofi Pasteur's Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced topline results of a large-scale, multi-center...


05 Aug, 2013, 14:50 ET Sanofi Pasteur Initiates Phase III Study of Investigational Clostridium difficile Vaccine in the United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program...


25 Jul, 2013, 08:00 ET Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone® (Influenza...


17 Jun, 2013, 08:00 ET Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the launch of Headfirst! Expert Advice on Lice, an...


10 Jun, 2013, 07:00 ET New Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration has...


05 Jun, 2013, 13:33 ET Emmy® Award-Winning Actress Sarah Michelle Gellar Joins March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign

 Actress and mother of two Sarah Michelle Gellar is joining March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign to...


23 Apr, 2013, 08:00 ET U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), and KaloBios Pharmaceuticals (Nasdaq:...